D. Vasile
Impact in
- Pharmacology top 2%
- Cannabis and Cannabinoid Research
- Biological Psychiatry top 10%
Papers in
-
- Treatment of Major Depression 6
- Cannabis and Cannabinoid Research 2
-
- COVID-19 and Mental Health 2
- Co-authors
- Philip Robson (2 shared papers)Rachel Barron (2 shared papers)Wiesław Jerzy Cubała (2 shared papers)Philip McGuire (2 shared papers)Stephen Wright (2 shared papers)Adam Taylor (2 shared papers)Paul D. Morrison (1 shared paper)Octavian Vasiliu (23 shared papers)
- Journals
- European Neuropsychopharmacology (8 papers)European Psychiatry (4 papers)International journal of communication (1 paper)American Journal of Psychiatry (1 paper)Clinical Neuropharmacology (1 paper)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
D. Vasile
22 papers receiving 497 citations
D. Vasile's Hit Papers
Peers
Comparison fields: 5 of 68
- Pharmacology 407
- Biological Psychiatry 35
- Psychiatry and Mental health 123
- Cellular and Molecular Neuroscience 107
- Toxicology 13
Countries citing papers authored by D. Vasile
This map shows the geographic impact of D. Vasile's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Vasile with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Vasile more than expected).
Fields of papers citing papers by D. Vasile
This network shows the impact of papers produced by D. Vasile. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Vasile. The network helps show where D. Vasile may publish in the future.
Co-authors
The 22 scholars most cited alongside D. Vasile, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial Hit paper breakdown → | 2017 | 458 |
| 2 | 2016 | 7 | |
| 3 | 2014 | 6 | |
| 4 | 2011 | 6 | |
| 5 | Translational approaches in treatment-resistant depression based on animal model. | 2018 | 5 |
| 6 | 2018 | 5 | |
| 7 | 2015 | 5 | |
| 8 | 2010 | 5 | |
| 9 | 2006 | 5 | |
| 10 | 2010 | 4 | |
| 11 | 2018 | 4 | |
| 12 | 2020 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2013 | 4 | |
| 15 | 2014 | 3 | |
| 16 | Cell Phone Addiction: A Review of the Available Data | 2017 | 2 |
| 17 | 2021 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2018 | 2 | |
| 20 | 2013 | 2 |
About D. Vasile
D. Vasile is a scholar working on Pharmacology, Clinical Psychology, Psychiatry and Mental health, Experimental and Cognitive Psychology and Social Psychology, having authored 31 papers that have together received 539 indexed citations. Recurring topics across this work include Treatment of Major Depression (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (4 papers), Schizophrenia research and treatment (4 papers), Bipolar Disorder and Treatment (3 papers), Impact of Technology on Adolescents (2 papers), Digital Mental Health Interventions (2 papers), Cannabis and Cannabinoid Research (2 papers) and COVID-19 and Mental Health (2 papers). The work is most often cited by research in Pharmacology (407 citations), Biological Psychiatry (35 citations), Psychiatry and Mental health (123 citations), Cellular and Molecular Neuroscience (107 citations) and Toxicology (13 citations). D. Vasile has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Philip Robson, Rachel Barron, Wiesław Jerzy Cubała, Philip McGuire, Stephen Wright, Adam Taylor, Paul D. Morrison, Octavian Vasiliu, Paul Morrison and Marius Moga. Their work appears in journals such as European Neuropsychopharmacology, European Psychiatry, International journal of communication, American Journal of Psychiatry and Clinical Neuropharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.